Form 4: Catalyst Pharmaceuticals Executive Reports Stock Transaction
Insider Transaction (Form 4)
William T. Andrews, Chief Medical Officer of Catalyst Pharmaceuticals, Inc., reported multiple transactions in common stock on July 15, 2026.
Summary
- Disposition to the issuer: disposed of 2,309 Common Stock, par value $0.001 per share at $31.50 ($72,734) on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 124,447 Options to purchase common stock on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 98,652 Options to purchase common stock on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 12,209 Restricted Stock Units on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 29,776 Restricted Stock Units on July 15, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
William T. Andrews — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Disposition to the issuer | Common Stock, par value $0.001 per share | 2,309 | $32 | $72.7K | 0 |
| 2026-07-15 | Disposition to the issuer | Options to purchase common stock | 124,447 | — | — | 0 |
| 2026-07-15 | Disposition to the issuer | Options to purchase common stock | 98,652 | — | — | 0 |
| 2026-07-15 | Disposition to the issuer | Restricted Stock Units | 12,209 | — | — | 0 |
| 2026-07-15 | Disposition to the issuer | Restricted Stock Units | 29,776 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Disposition to the issuer (2,309 shares) |
| 2026-07-15 | Disposition to the issuer (124,447 shares) |
| 2026-07-15 | Disposition to the issuer (98,652 shares) |
| 2026-07-15 | Disposition to the issuer (12,209 shares) |
| 2026-07-15 | Disposition to the issuer (29,776 shares) |
Keywords
insider transaction, Form 4, CPRX, CATALYST PHARMACEUTICALS, INC., neutral, William T. Andrews
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.